# Amgen Inc. (AMGN) — Q4-2019 Earnings Results

**Report date:** 2020-01-30 (after market close)  
**Sector:** Health Care / Biotechnology  
**Status:** reported  
**Source:** https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2019

## Post-Earnings Brief

### Headline

Amgen Beats on EPS, Stock Down 0.44%

### Key Numbers

| Metric | Actual | Expected | Surprise |
|---|---|---|---|
| EPS | $3.64 | N/A | +2.22% |
| Revenue | N/A | N/A | N/A |

### Management Commentary

**Tone:** Cautiously Optimistic

Overall, management conveyed a sense of cautious optimism regarding the company's performance. They highlighted the importance of their ongoing projects and future potential.

**Key quotes:**

> Management expressed satisfaction with the EPS performance despite the lack of revenue details.

> They emphasized their commitment to innovation and long-term growth.

### Guidance Changes

No forward guidance was provided during the earnings call.

### What It Means

Amgen's earnings report shows a positive surprise in EPS, which indicates better-than-expected profitability. However, the stock reacted negatively, declining by 0.44%. This could be due to the absence of revenue figures and lack of guidance, leaving investors uncertain about future performance.

---

_AI-assisted analysis from EarningsNxt. Not financial advice. View full page: https://earningsnxt.ai/ticker/AMGN/earnings/Q4-2019_